Helen Pearce

742 total citations
6 papers, 569 citations indexed

About

Helen Pearce is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Helen Pearce has authored 6 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Helen Pearce's work include HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers) and HIV-related health complications and treatments (3 papers). Helen Pearce is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers) and HIV-related health complications and treatments (3 papers). Helen Pearce collaborates with scholars based in United Kingdom, Spain and Germany. Helen Pearce's co-authors include Chloe Orkin, Juliet Compston, José Ramón Arribas, Hans‐Jürgen Stellbrink, Adriano Lazzarin, John S. Lambert, Jan Gerstoft, Patrizia Zucchi, Sara Hughes and Eric Van Wijngaerden and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Helen Pearce

6 papers receiving 561 citations

Peers

Helen Pearce

ID

EM

VIROL

OSM

PFM

Patrizia Zucchi Italy

Gunta Stūre Latvia

Ei Kinai Japan

Sílvia Gel Spain

Haruhito Honda Japan

Sara Bañón Spain

Martin Gartland United Kingdom

Tanakorn Apornpong Thailand

Luigi Pusterla Italy

Marilyn McMurchie Australia

Patrizia Zucchi Italy

Helen Pearce

295 ×0.8

ID

270 ×0.7

EM

138 ×0.6

VIROL

137 ×0.9

OSM

58 ×0.8

PFM

Citations per year, relative to Helen Pearce Helen Pearce (= 1×) peers Patrizia Zucchi

Countries citing papers authored by Helen Pearce

Since Specialization

Citations

This map shows the geographic impact of Helen Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Pearce more than expected).

Fields of papers citing papers by Helen Pearce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Pearce. The network helps show where Helen Pearce may publish in the future.

Co-authorship network of co-authors of Helen Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Pearce. A scholar is included among the top collaborators of Helen Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Pearce. Helen Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pearce, Helen, et al.. (2024). A Novel Case of CMV Resistance to Valganciclovir and Maribavir in a Renal Transplant Patient. Transplant International. 37. 11985–11985. 2 indexed citations

2.

Pearce, Helen & Holly Mabillard. (2023). Finerenone and other future therapeutic options for Alport syndrome. SHILAP Revista de lepidopterología. 2(1). 18–18. 1 indexed citations

3.

Moyle, Graeme, Hans‐Jürgen Stellbrink, Juliet Compston, et al.. (2013). 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Antiviral Therapy. 18(7). 905–913. 52 indexed citations

4.

Orkin, Chloe, Jianmin Wang, Colm Bergin, et al.. (2010). An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe. Pharmacogenetics and Genomics. 20(5). 307–314. 31 indexed citations

5.

Post, Frank A., Graeme Moyle, Peré Domingo, et al.. (2010). Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 49–57. 168 indexed citations

6.

Stellbrink, Hans‐Jürgen, Chloe Orkin, José Ramón Arribas, et al.. (2010). Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study. Clinical Infectious Diseases. 51(8). 963–972. 315 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact